APPLIED GENETIC TECHNOLOGIES CORPORATION: AGTC Announces Sue Washer, CEO, Elected to Biotechnology Innovation Organization's Board of Directors

Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced the election of Sue Washer, President and Chief Executive Officer, to the Biotechnology Innovation Organization (BIO)'s Board of Directors. Read More »